CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory to Sales
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Integrated Biopharma Inc  (INBP)
Other Ticker:  
 
 

Integrated Biopharma Inc Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Integrated Biopharma Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2024 to a ratio of 11.42, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2024. Average collection period, for Integrated Biopharma Inc's accounts receivable remained unchanged at 32 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 11 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 166, from overall ranking in the first quarter 2024 at 208.

What is Receivable Turnover Ratio?
What is Integrated Biopharma Inc Selling?


What is Receivable Turnover Ratio?




INBP Receivables Turnover Ratio (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter		 (Jun 30 2023)
IV. Quarter		 (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter
Y / Y Receivable Change -17.21 % 12.42 % -7.71 % -24.1 % -17.52 %
Y / Y Revenue Change -14.15 % 4.11 % -6.66 % -16.22 % -16.03 %
Receivable Turnover Ratio (TTM) 11.42 11.32 11.5 11.45 11.1
INBP's Total Ranking # 166 # 208 # 123 # 226 # 835
Average receivable collection period 32 32 32 32 33
Seq. Receivable Change -10.52 % -7.51 % -3.67 % 3.86 % 21.5 %
Seq. Revenue Change -18.02 % 3.63 % -5.46 % 6.89 % -0.58 %

New: More INBP's historic Receivables Turnover Ratios >>

Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 12
Overall Market # 166

Receivable Turnover Ratio Statistics
High Average Low
3.28 2.59 1.87
(Mar 31 2017)   (Dec 31 2023)





INBP Company Profile • Back to INBP Efficiency Comparisons • Compare INBP Receivables Turnover Ratio to its Competitors

Financial Statements
Integrated Biopharma Inc's Accounts Receivable $ 4 Millions Visit INBP's Balance sheet
Integrated Biopharma Inc's Sales TTM $ 49 Millions Visit INBP's Income Statement
Where are INBP's Sales coming from? Visit INBP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
INBP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for INBP's Competitors
Receivables Turnover Ratio for INBP's Suppliers
Accounts Receivables Turnover Ratio for INBP's Customers

You may also want to know
INBP's Growth Rates INBP's Roa INBP's Inventory Turnover Ratio INBP's Dividend Comparisons
INBP's Profitability Ratios INBP's Roi INBP's Asset Turnover Ratio INBP's Dividend Growth
INBP's Valuation Ratios INBP's Roe INBP's Financial Strength Ratios INBP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Electrocore Inc   34.66 $ 15.226  Millions$ 0.439  Millions
Sonida Senior Living Inc   34.44 $ 255.322  Millions$ 7.413  Millions
Prothena Corporation Public Limited Company  33.71 $ 91.370  Millions$ 2.711  Millions
National Vision Holdings Inc   26.38 $ 2,126.468  Millions$ 80.611  Millions
Inmed Pharmaceuticals Inc   25.66 $ 6.218  Millions$ 0.242  Millions
Orchestra Biomed Holdings Inc   25.56 $ 2.760  Millions$ 0.108  Millions
Cano Health Inc   24.48 $ 3,137.757  Millions$ 128.172  Millions
Icecure Medical Ltd   22.33 $ 2.300  Millions$ 0.103  Millions
Editas Medicine Inc   20.64 $ 78.123  Millions$ 3.784  Millions
Cue Health Inc   20.01 $ 70.936  Millions$ 3.545  Millions
Fsd Pharma Inc   19.91 $ 4.556  Millions$ 0.229  Millions
Innovage Holding Corp   19.58 $ 720.796  Millions$ 36.806  Millions
Kiniksa Pharmaceuticals ltd   19.17 $ 270.259  Millions$ 14.095  Millions
Pieris Pharmaceuticals Inc   18.84 $ 42.810  Millions$ 2.273  Millions
Neptune Wellness Solutions Inc   18.45 $ 39.115  Millions$ 2.120  Millions
Valneva Se  18.11 $ 172.159  Millions$ 9.509  Millions
Ensysce Biosciences Inc   17.55 $ 3.385  Millions$ 0.193  Millions
Biofrontera Inc   17.48 $ 116.349  Millions$ 6.657  Millions
Halozyme Therapeutics Inc   17.02 $ 829.253  Millions$ 48.721  Millions
Qhslab Inc   16.93 $ 1.409  Millions$ 0.083  Millions
Recursion Pharmaceuticals Inc   15.69 $ 44.575  Millions$ 2.842  Millions
Owens and Minor inc  15.24 $ 10,333.161  Millions$ 677.813  Millions
Milestone Scientific Inc   15.03 $ 9.793  Millions$ 0.651  Millions
Neuroone Medical Technologies Corporation  14.87 $ 2.816  Millions$ 0.189  Millions
Chemed Corporation  14.52 $ 2,264.417  Millions$ 155.918  Millions
Icu Medical Inc  14.46 $ 2,259.126  Millions$ 156.262  Millions
Lftd Partners Inc   14.38 $ 51.611  Millions$ 3.588  Millions
Patterson Companies Inc   14.11 $ 6,565.239  Millions$ 465.318  Millions
Corcept Therapeutics Inc  13.70 $ 482.375  Millions$ 35.215  Millions
Theralink Technologies Inc   13.67 $ 0.511  Millions$ 0.037  Millions

Date modified: 2024-02-13T09:07:52+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com